Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging
Theranostics
2015
618-630
The Influence of the Combination of Carboxylate and Phosphinate Pendant Arms in 1,4,7-Triazacyclononane-Based Chelators on Their 68Ga Labelling Properties
Molecules
2015
20
13112-13126
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
Journal of Nuclear Medicine
2015
56
1169-1176
Biodistribution and Radiation Dosimetry for a Probe Targeting Prostate-Specific Membrane Antigen for Imaging and Therapy
Journal of Nuclear Medicine
2015
56
855-861
Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
Journal of Nuclear Medicine
2015
56
668-674
Biodistribution and Radiation Dosimetry for the Chemokine Receptor CXCR4-Targeting Probe 68Ga-Pentixafor
Journal of Nuclear Medicine
2015
56
410-416
89Zr-Labeled Versus 124I-Labeled HER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo
Journal of Nuclear Medicine
2015
56
1112-1118
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
EMBO Molecular Medicine
2015
477-487
Multiparametric MR and PET Imaging of Intratumoral Biological Heterogeneity in Patients with Metastatic Lung Cancer Using Voxel-by-Voxel Analysis
PLOS ONE
2015
10
e0132386
[111In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery
EJNMMI Research
2015